Skip to main content

Table 5 Causes of treatment discontinuation for the two age groups

From: The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients

 

Aged < 65 years group(n= 33)

Aged ≥ 65 years group(n= 15)

Anemia

9

5

Thrombopenia

9

3

General fatigue

7

3

Poor response to therapy

8

4